Ammar Abdulrazzak, MD (@ARazzakMD) profile picture

Endovascular Neurointerventional Staff @Clevelandclinic

Cleveland, OH
Joined March 2019
Photo by Ammar Abdulrazzak, MD (@ARazzakMD)Photo by Ammar Abdulrazzak, MD (@ARazzakMD)Photo by Ammar Abdulrazzak, MD (@ARazzakMD)Photo by Ammar Abdulrazzak, MD (@ARazzakMD)Photo by Ammar Abdulrazzak, MD (@ARazzakMD)Photo by Ammar Abdulrazzak, MD (@ARazzakMD)Photo by Ammar Abdulrazzak, MD (@ARazzakMD)Photo by Ammar Abdulrazzak, MD (@ARazzakMD)Photo by Ammar Abdulrazzak, MD (@ARazzakMD)Photo by Ammar Abdulrazzak, MD (@ARazzakMD)
Ammar Abdulrazzak, MD retweeted
.@amrsarrajMD presents ATLAS meta-analysis data demonstrating an "overwhelming benefit" with thrombectomy in large-core ischaemic strokes across six RCTs, with the only potential exception being core volumes ≥150ml presenting beyond six hours #ESOC2026 @ESOstroke
16
30
2,602
It is a great privilege to contribute to this landmark study - a pioneering effort that advances the frontiers of knowledge and offers new hope to those with most severe stroke. Congratulations @amrsarrajMD and all co-authors and contributors on this outstanding achievement.
On behalf of the large core trials principal investigators, immensely proud and honored to present primary results of the ATLAS IPD meta-analysis @ESOstroke with simultaneous publication in @TheLancet -thelancet.com/journals/lance… EVT not only improved outcomes compared to medical care, but functional independence and independent ambulation were also achieved in a meaningful proportion of patients. Additionally, EVT was life-saving, as one of the few reperfusion therapies to achieve it. With the exception of patients with very large core (volume ≥150 ml) in the late time window, where evidence is limited because of wide confidence intervals but benefit could not be excluded, EVT demonstrated consistent benefit regardless of ASPECTS and ischaemic core strata. Our deepest gratitude to the patients, their families, and all investigators and coordinators at the trial sites. A mammoth collective effort over 3 years from 6 trials with practice changing results that improve care for 20% LVOs! #stroke #EVT #largecore #NoLVOleftbehind @XiaochuanHuo @VCostalat @oozaidat @VYogendrakumar @deeppujara @dliebesk @ARazzakMD @NguyenThanhMD @samialkasab @AmeerEHassan @Michael3Abraham @FelixSun1230 @HiroshiYamagam2 @SunilAShethMD @Fie0815 @RaulNogueiraMD @rgrandhi @PascalJabbourMD @shazamhussain @dr_mchen @mihill68 @lapergue6 @TudorGJovin @AlbertJYoo
1
2
122
Ammar Abdulrazzak, MD retweeted
🚀 Thinking about a career in #InterventionalNeurology? Get insider tips & your ultimate match playbook from leading experts! 📅 Aug 14 | ⏰ 6–7 PM EST 💡 Learn pathways, strategies & how to stand out 🔗 Register now: bit.ly/4lazlNp
1
18
68
3,650
Ammar Abdulrazzak, MD retweeted
PICASSO (Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem Lesion or Local Occlusion)  Thrombectomy Randomized Trial: Study Protocol and Rationale | Stroke: Vascular and Interventional Neurology ahajournals.org/doi/10.1161/…
14
44
2,169
Thank you @shazamhussain & @GaborTothMD for organizing an incredible meeting this year! Great talks, debates, and cutting-edge innovations. #IICC2025 @ClevelandClinic looking forward to next year’s meeting!
It’s a wrap! Our last session, “Acute Ischemic Stroke”, has concluded, and so has the @CleClinicMD Cerebrovascular Center #Innovations in #Cerebrovascular Care Conference 2025! ccfcme.org/iicc @CleClinicMD @CleClinicNS @CLENeurons @CleveClinicFL @CCAD
2
9
992
Ammar Abdulrazzak, MD retweeted
Continuing the @CleClinicMD Neurological Institute Cerebrovascular Center Innovations in Cerebrovascular Care Conference with more venous disorders ccfcme.org/iicc @NinaZMoore @sidonieibrikji @ARazzakMD @SebyJohnMD @DhimantDaniMD presenting and discussing!
4
8
541
Ammar Abdulrazzak, MD retweeted
#STROKE: Review by @amrsarrajMD et al. of the six recent RCTs of thrombectomy in large core strokes with the exploration of what expanding eligibility could mean for stroke care systems and society. #ESOC2025 #AHAJournals ahajournals.org/doi/full/10.…
2
32
1
88
6,999
Ammar Abdulrazzak, MD retweeted
Registration is now open! ccfcme.org/IICC Join us this year for our Innovations in Cerebrovascular Care conference on June 10-11, 2025. Superb program, hot #neuroendovascular and #cerebrovascular topics with fantastic speaker lineup
2
8
26
1,925
The RED 43 catheter for aspiration thrombectomy of distal medium vessel occlusions (DMVOs): a multicenter experience | Journal of NeuroInterventional Surgery jnis.bmj.com/content/early/2…
1
1
197
Ammar Abdulrazzak, MD retweeted
Volumetric basal ganglia hemorrhage morphology predicts postoperative functional outcome after MIS evacuation jnis.bmj.com/content/early/2…
4
1
8
1,956
Ammar Abdulrazzak, MD retweeted
Congratulations @AmeerEHassan @Michael3Abraham on leading analyses on effect of procedure characteristics and reperfusion success on EVT outcomes for patients with large strokes from @SELECT2Trial onlinelibrary.wiley.com/doi/… @ANA_journals ~80% procedural success that improved clinical outcomes and reduced infarct growth. eTICI 2c-3 improved outcomes compared to those with eTICI 2b. Prolonged procedures were associated with worse outcomes. Consistent results across aspiration first vs stent retriever approaches. @shazamhussain, @CerebrovascLab, @dr_mchen, @deeppujara, @NabeelHerial, @JPTsaiMD, @DrPatchiz, @drricardohanel, @almuftifawaz, @AndrewKCheung, @jordiblascoa, @LUISANROMA, @NiravAVora, @DanSahlein, @LElijovich, @ArenillasJF, @Teddyyhwu, @PCardonaP, @natperezossa, @JoannaSchaafsma, @BJHicksMD, @NaviSSangha, @warach_steven, @TimothyKleinig, @Faris_Shaker, @FreqFrequentist, @wondeasa, @mark_dannenbaum, @GaborTothMD, @AmuluruKrishna, @JanKarlBurkhar1, @ARazzakMD,  @HarisKamalMD, @vitorpereiracan, @NguyenThanhMD, @Johannatfifi, @esamaniego, @AdamArthurMD, @StavTjoumakaris, @PascalJabbourMD, @jimgrotta, @mihill68, @marcriboj
16
49
2,870
Ammar Abdulrazzak, MD retweeted
How is it time for interview season already?! 😳 @CLENeurons & I will be hosting our first open house, TONIGHT! Hope you’ll join to learn a bit more about us, our program, & city. Also, welcome all applicants to the 2024-2025 match! I’m biased, but neuro is the best 🧠💪🏼
1
2
1
37
5,148
Ammar Abdulrazzak, MD retweeted
10 years ago today, the @ClevelandClinic #mobilestroke treatment unit launched setting up a new paradigm for stroke care. Very proud to celebrate this important anniversary! Thank you to everyone who makes this great care possible everyday .
4
11
1
95
3,915
Ammar Abdulrazzak, MD retweeted
Wonderful second day to our Innovations in Cerebrovascular Care 2024 meeting! I personally learned a lot from the debates and panel discussions. Hope everyone also enjoyed. Hopefully see you next year! @BlakeBuletko @DineshJillella @1jasonmathew @AbbasKharalMD @GaborTothMD
1
26
1,176
Ammar Abdulrazzak, MD retweeted
Proud to be a part of this important trial. Congratulations to @bainmd Joao Gomes and ENRICH trial authors
In the ENRICH trial of minimally invasive cerebral hematoma removal within 24 hours after onset of hemorrhage, functional outcomes were better with surgery than with medical treatment, particularly among patients with lobar hemorrhages. Full trial results: nej.md/3VPYggf
4
5
55
4,445
Ammar Abdulrazzak, MD retweeted
Congrats @bainmd @JAGrossbergMD @JMDaviesMDPhD and the ENRICH team for a paradigm-shifting trial!
In the ENRICH trial of minimally invasive cerebral hematoma removal within 24 hours after onset of hemorrhage, functional outcomes were better with surgery than with medical treatment, particularly among patients with lobar hemorrhages. Full trial results: nej.md/3VPYggf
4
22
2,516
Ammar Abdulrazzak, MD retweeted
Total solar eclipse in Cleveland. Happy to have a short down time in between cases to capture this! @ClevelandClinic – at Cleveland, OH
14
184
18
1,597
155,454